Heart HealthSenescent Cells and the Aging Heart: What the Evidence Really Supports
As we age, some heart and blood vessel cells stop dividing and turn into "senescent" cells that release inflammatory signals. This review sorts the cardiovascular senescence literature by cell type and by strength of evidence. Senescence looks different in vessel lining cells, smooth muscle, heart muscle, scar-forming fibroblasts, immune cells and repair cells, and its effects depend on timing. Most mechanistic proof comes from cultured cells and animals, while human heart data are mostly observational. Drugs that clear or calm senescent cells have shown encouraging results in animals, and one (navitoclax) appeared harmful in advanced plaque. No senescence-targeted therapy has yet shown a cardiovascular benefit in people. The authors call for better biomarkers and trials that measure heart and vascular function.